Definitive mechanistic clarification will require experimental studies such as CRISPR/Cas9-mediated knockdown or overexpression, rescue assays to confirm pathway dependency, and in vivo tumor models to evaluate how HMGA1 influences immune cell dynamics within the tumor microenvironment. This evidence concerns the gene HMGA1 and neoplasm.